CoChat

Physician Attitudes Toward the Use of Fecal Transplantation for Recurrent Clostridium difficile Infection in a Metropolitan Area

Jiang, Z.-D., Hoang, L. N., Lasco, T. M., Garey, K. W., DuPont, H. L. · 2013 · Clinical Infectious Diseases
Cited by 23

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

In the United States and Canada there has been an alarming increase in the incidence and severity of Clostridium difficile infection (CDI) in the last decade [1]. It is now estimated that between 500 000 and 700 000 cases of CDI occur in US hospitals annually, with an estimated hospital excess cost of care of approximately $3.2 billion [2, 3]. With the increase in risk of developing CDI, high rates of disease recurrence are being seen without the availability of adequate treatment [4, 5]. It is now accepted that disruption of the normal balance of colonic microbiota secondary to antibiotic use facilitates the development of CDI and that improvements in the quality and quantity of flora are associated with recovery of infection and disease recurrence. Studies have shown that patients with recurrent CDI have decreased anaerobic Bacteroidetes and Firmicutes in their stool compared to patients recovering from single episodes of CDI [6]. Numerous case reports and retrospective case series have demonstrated benefit of fecal transplantation (FT) in patients with severe or recurrent CDI with cure rates of >90% [7–12]. Fecal transplantation involves administration of a suspension of feces obtained from a healthy individual into the colon of a patient with recurrent CDI to promote normalization of flora and inhibition of the infecting C. difficile [8]. Probiotics have been used widely for patients with CDI in efforts to repair the disruption of microbiota, leading to prevention and control of CDI [13]; however, the available probiotics have been shown to have a limited effect, failing to reach the efficacy of fecal transplantation from a healthy volunteer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/cid/cis1025

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

Metadata

Authors
Jiang, Z.-D., Hoang, L. N., Lasco, T. M., Garey, K. W., & DuPont, H. L.
Venue
Clinical Infectious Diseases
Published
2012-12-07
Volume
56
Issue
7
Pages
1059-1060
ISSN
  • 1058-4838 (ISSN-L)
  • 1537-6591
OpenAlex
W2101916417
Cited by
23
References
3
FWCI
2.63
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.